98 related articles for article (PubMed ID: 16753356)
1. Nonsurgical management of Peyronie's disease--are we making any progress?
Meacham RB
J Urol; 2006 Jul; 176(1):12-3. PubMed ID: 16753356
[No Abstract] [Full Text] [Related]
2. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease.
Hellstrom WJ; Kendirci M; Matern R; Cockerham Y; Myers L; Sikka SC; Venable D; Honig S; McCullough A; Hakim LS; Nehra A; Templeton LE; Pryor JL
J Urol; 2006 Jul; 176(1):394-8. PubMed ID: 16753449
[TBL] [Abstract][Full Text] [Related]
3. Intralesional Injection of Interferon-α2b Improves Penile Curvature in Men with Peyronie's Disease Independent of Plaque Location.
Stewart CA; Yafi FA; Knoedler M; Mandava SH; McCaslin IR; Sangkum P; Sikka S; Trost L; Hellstrom WJ
J Urol; 2015 Dec; 194(6):1704-7. PubMed ID: 26144333
[TBL] [Abstract][Full Text] [Related]
4. Intralesional interferon-alpha-2b for the treatment of Peyronie's disease.
Lacy GL; Adams DM; Hellstrom WJ
Int J Impot Res; 2002 Oct; 14(5):336-9. PubMed ID: 12454683
[TBL] [Abstract][Full Text] [Related]
5. Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: a randomized and prospective study.
Inal T; Tokatli Z; Akand M; Ozdiler E; Yaman O
Urology; 2006 May; 67(5):1038-42. PubMed ID: 16581113
[TBL] [Abstract][Full Text] [Related]
6. Peyronie's disease: intralesional treatment with interferon alpha-2A and evaluation of the results by magnetic resonance imaging.
Polat O; Gül O; Ozbey I; Ozdikici M; Bayraktar Y
Int Urol Nephrol; 1997; 29(4):465-71. PubMed ID: 9406006
[TBL] [Abstract][Full Text] [Related]
7. Intralesional Interferon-α2b Improves Penile Curvature in Peyronie's Disease.
Milam DF
J Urol; 2015 Dec; 194(6):1533. PubMed ID: 26386274
[No Abstract] [Full Text] [Related]
8. The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's disease.
Kendirci M; Usta MF; Matern RV; Nowfar S; Sikka SC; Hellstrom WJ
J Sex Med; 2005 Sep; 2(5):709-15. PubMed ID: 16422829
[TBL] [Abstract][Full Text] [Related]
9. Intralesional injection therapy for Peyronie's disease.
Hellstrom WJ; Cockerham YR
J Sex Med; 2009 Jul; 6(7):1811-4. PubMed ID: 19575773
[No Abstract] [Full Text] [Related]
10. Combined intralesional interferon alpha 2B and oral vitamin E in the treatment of Peyronie's disease.
Novak TE; Bryan W; Templeton L; Sikka S; Hellstrom WJ
J La State Med Soc; 2001 Jul; 153(7):358-63. PubMed ID: 11519219
[TBL] [Abstract][Full Text] [Related]
11. Intralesional interferon in the treatment of Peyronie's disease: a pilot study.
Judge IS; Wisniewski ZS
Br J Urol; 1997 Jan; 79(1):40-2. PubMed ID: 9043494
[TBL] [Abstract][Full Text] [Related]
12. A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease.
Ahuja S; Bivalacqua TJ; Case J; Vincent M; Sikka SC; Hellstrom WJ
J Androl; 1999; 20(4):444-8. PubMed ID: 10452584
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Duration of Penile Traction Therapy in Patients Undergoing Intralesional Injection Therapy for Peyronie's Disease.
Yafi FA; Pinsky MR; Stewart C; Sangkum P; Ates E; Trost LW; Sikka SC; Hellstrom WJ
J Urol; 2015 Sep; 194(3):754-8. PubMed ID: 25804087
[TBL] [Abstract][Full Text] [Related]
14. Local interferon-alpha 2b is not an effective treatment in early-stage Peyronie's disease.
Wegner HE; Andresen R; Knispel HH; Miller K
Eur Urol; 1997; 32(2):190-3. PubMed ID: 9286652
[TBL] [Abstract][Full Text] [Related]
15. Is intralesional verapamil effective therapy for Peyronie's disease?
Levine LA; Costabile RA
J Urol; 2012 Sep; 188(3):704-6. PubMed ID: 22818342
[No Abstract] [Full Text] [Related]
16. A critical analysis of nonsurgical treatment of Peyronie's disease.
Hauck EW; Diemer T; Schmelz HU; Weidner W
Eur Urol; 2006 Jun; 49(6):987-97. PubMed ID: 16698449
[TBL] [Abstract][Full Text] [Related]
17. Review of current nonsurgical management of Peyronie's disease.
Levine LA
Int J Impot Res; 2003 Oct; 15 Suppl 5():S113-20. PubMed ID: 14551587
[TBL] [Abstract][Full Text] [Related]
18. [Peyronie's disease: comparative results of conservative treatment].
Kovalev VA; Karaguzhin SK; Abdulkhamidov AN; Danovich VM; Kyzlasov PS; Matskevich SV
Urologiia; 2010; (6):40-4. PubMed ID: 21427993
[TBL] [Abstract][Full Text] [Related]
19. The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study.
Jordan GH
J Sex Med; 2008 Jan; 5(1):180-7. PubMed ID: 18173766
[TBL] [Abstract][Full Text] [Related]
20. Are the current conservative treatments for Peyronie's disease evidence-based?
Gontero P; Frea B
BJU Int; 2004 Jul; 94(1):3-4. PubMed ID: 15217420
[No Abstract] [Full Text] [Related]
[Next] [New Search]
